Days after grabbing headlines with its COVID-19 'vaccine for the world,' AstraZeneca is facing tricky questions about its success rate that some experts say could hinder its chances of getting speedy U.S. and EU regulatory approval.
Business & Financial News, U.S & International Breaking News
Exclusive: Iraq trains U.S.-sanctioned militia leader for army position - sources
The Iraqi military is training a former member of an Iran-backed militia, who is under U.S. sanctions for killing protesters, to become a high-ranking officer in the army, according to six government, security and militia officials.
Australia says 13 soldiers told they face dismissal after Afghan report
Australia has told 13 special forces soldiers they face dismissal in relation to a report on alleged unlawful killings in Afghanistan, the head of the country's army said on Friday.
Rome airport to offer COVID-tested flights to U.S. with Delta, Alitalia
Rome's Fiumicino airport will run COVID-tested flights to and from the United States operated by Delta Air Lines and Alitalia, it said on Thursday, adding it will be the first airport in Europe to offer the service on transatlantic flights.
Disney increases planned layoffs to 32,000 as virus hits park attendance
Walt Disney Co said on Wednesday it would lay off about 32,000 workers, primarily at its theme parks, an increase from the 28,000 it announced in September, as the company struggles with limited customers due to the coronavirus pandemic.
Britain to curb Google and Facebook with tougher competition rules
Britain will impose a new competition regime next year to prevent Google and Facebook using their dominance to push out smaller firms and disadvantage consumers.
Hong Kong activist tells German paper he's doing well in prison isolation
Hong Kong pro-democracy activist Joshua Wong told a German newspaper he was doing well despite being held in solitary confinement and having trouble sleeping because of bright lights after he was remanded in custody this week.
Have a news tip?
Reuters provides several ways to securely and confidentially share information and materials with our journalists.LEARN MORE ››